FDA Current Affairs, GK & News
After months of study, the FDA has concluded that the ranitidine drug contains unacceptable levels of carcinogenic impurities and called for its disposal. About the Issue The US Food and Drug Administration had tested the drug ranitidine over several months for presence of impurities. It discovered the presence of a carcinogenic substance called NDMA. It ..